M. K. Proteins Limited carries a market capitalization of 1.74B, placing it among publicly traded companies globally. Its enterprise value stands at 1.82B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.74B |
| Enterprise Value | 1.82B |
M. K. Proteins Limited currently has 375.37M shares outstanding.
| Shares Outstanding | 375.37M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
M. K. Proteins Limited trades at a trailing price-to-earnings ratio of 21.32. The price-to-sales ratio is 0.38, and the price-to-book ratio stands at 3.88.
| PE Ratio | 21.32 |
| PS Ratio | 0.38 |
| PB Ratio | 3.88 |
| P/TBV Ratio | 1.91 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, M. K. Proteins Limited trades at an EV/EBITDA multiple of 16.60 and an EV/FCF ratio of 135.31. The EV/Sales ratio of 0.48 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.60 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.48 |
| EV / EBITDA | 16.60 |
| EV / EBIT | 16.60 |
| EV / FCF | 135.31 |
M. K. Proteins Limited maintains a current ratio of 2.25, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 48.67, indicating elevated leverage, while an interest coverage ratio of 5.93 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 2.25 |
| Quick Ratio | 0.01 |
| Debt / Equity | 48.67 |
| Debt / EBITDA | 3.38 |
| Interest Coverage | 5.93 |
M. K. Proteins Limited posts a return on equity of 12.76 and a return on invested capital of 7.14.
| Return on Equity (ROE) | 12.76 |
| Return on Assets (ROA) | 5.22 |
| Return on Invested Capital (ROIC) | 7.14 |
| Return on Capital Employed (ROCE) | 8.94 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.31 |
Over the trailing twelve months, M. K. Proteins Limited has paid 25.60M in income taxes, reflecting an effective tax rate of 27.26.
| Income Tax | 25.60M |
| Effective Tax Rate | 27.26 |
M. K. Proteins Limited's stock has declined approximately -36.60834% over the past 52 weeks. The 50-day moving average sits at 5.02, while the 200-day moving average is 5.66.
| Beta (5Y) | N/A |
| 52-Week Price Change | -36.60834% |
| 50-Day Moving Average | 5.02 |
| 200-Day Moving Average | 5.66 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, M. K. Proteins Limited generated 3.83B in revenue and converted that into 68.29M in net income, yielding earnings per share of 0.18. EBITDA reached 109.81M, while operating income came in at 109.81M.
| Revenue | 3.83B |
| Gross Profit | 172.86M |
| Operating Income | 109.81M |
| Pretax Income | 93.89M |
| Net Income | 68.29M |
| EBITDA | 109.81M |
| EBIT | 109.81M |
| Earnings Per Share (EPS) | 0.18 |
M. K. Proteins Limited holds 4.38M in cash and equivalents against 371.38M in total debt, resulting in a net debt position of 357.50M. Total book value stands at 375.37M, with working capital of 656.85M providing operational flexibility.
| Cash & Cash Equivalents | 4.38M |
| Total Debt | 371.38M |
| Net Debt | 357.50M |
| Equity (Book Value) | 375.37M |
| Book Value Per Share | 1.00 |
| Working Capital | 656.85M |
M. K. Proteins Limited operates with a gross margin of 4.51, reflecting its pricing power and cost economics. The operating margin of 2.87 and net profit margin of 1.78 provide insight into operational efficiency.
| Gross Margin | 4.51 |
| Operating Margin | 2.87 |
| Pretax Margin | 2.45 |
| Profit Margin | 1.78 |
| EBITDA Margin | 2.87 |
M. K. Proteins Limited's most recent stock split took place on March 15, 2024 with a 1:3 split ratio.
| Last Split Date | 3/15/2024 |
| Split Ratio | 1:3 |
M. K. Proteins Limited posts an Altman Z-Score of 5.39, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.39 |